APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Selected research

Market Outlook & Growth Opportunities

Global Vaccines Market Outlook and Growth Opportunities 2026

1 January 2026197 pages

Choose your research edition.

Industry ResearchVaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.

This report provides an overview of the global Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccines Segment by Company

GSK

Sanofi

Merck

Pfizer

Novartis(GSK)

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Jintan

Vaccines Segment by Type

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Vaccines Segment by Application

Rabies vaccine

Influenza vaccine

HPV vaccine

Hepatitis B

Hepatitis A

Leprosy vaccine

Polio vaccine

JE vaccine

Others

Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccines industry.

Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vaccines Industry Trends Table 2. Vaccines Industry Drivers Table 3. Vaccines Industry Opportunities and Challenges Table 4. Vaccines Industry Restraints Table 5. Global Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vaccines Revenue Share by Company (2021-2026) Table 7. Global Vaccines Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Vaccines Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Vaccines Company, Product Type & Application Table 13. Global Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Recombinant Vaccines Table 18. Significant Companies of Viral Vaccines Table 19. Significant Companies of Polysaccharide Vaccines Table 20. Significant Companies of Others Table 21. Global Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 22. Global Vaccines Sales Volume by Type (2021-2026) & (K Pcs) Table 23. Global Vaccines Sales Volume by Type (2027-2032) & (K Pcs) Table 24. Global Vaccines Sales Volume Share by Type (2021-2026) Table 25. Global Vaccines Sales Volume Share by Type (2027-2032) Table 26. Global Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Vaccines Sales Value Share by Type (2021-2026) Table 30. Global Vaccines Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Rabies vaccine Table 32. Significant Companies of Influenza vaccine Table 33. Significant Companies of HPV vaccine Table 34. Significant Companies of Hepatitis B Table 35. Significant Companies of Hepatitis A Table 36. Significant Companies of Leprosy vaccine Table 37. Significant Companies of Polio vaccine Table 38. Significant Companies of JE vaccine Table 39. Significant Companies of Others Table 40. Global Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 41. Global Vaccines Sales Volume by Application (2021-2026) & (K Pcs) Table 42. Global Vaccines Sales Volume by Application (2027-2032) & (K Pcs) Table 43. Global Vaccines Sales Volume Share by Application (2021-2026) Table 44. Global Vaccines Sales Volume Share by Application (2027-2032) Table 45. Global Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 47. Global Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 48. Global Vaccines Sales Value Share by Application (2021-2026) Table 49. Global Vaccines Sales Value Share by Application (2027-2032) Table 50. Global Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 51. Global Vaccines Sales by Region (2021-2026) & (K Pcs) Table 52. Global Vaccines Sales Market Share by Region (2021-2026) Table 53. Global Vaccines Sales by Region (2027-2032) & (K Pcs) Table 54. Global Vaccines Sales Market Share by Region (2027-2032) Table 55. Global Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 57. Global Vaccines Sales Value Share by Region (2021-2026) Table 58. Global Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 59. Global Vaccines Sales Value Share by Region (2027-2032) Table 60. Global Vaccines Market Average Price (US$/Pcs) by Region (2021-2026) Table 61. Global Vaccines Market Average Price (US$/Pcs) by Region (2027-2032) Table 62. Global Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 63. Global Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Vaccines Sales by Country (2021-2026) & (K Pcs) Table 65. Global Vaccines Sales Market Share by Country (2021-2026) Table 66. Global Vaccines Sales by Country (2027-2032) & (K Pcs) Table 67. Global Vaccines Sales Market Share by Country (2027-2032) Table 68. Global Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 69. Global Vaccines Sales Value Market Share by Country (2021-2026) Table 70. Global Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 71. Global Vaccines Sales Value Market Share by Country (2027-2032) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 75. GSK Vaccines Product Portfolio Table 76. GSK Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 80. Sanofi Vaccines Product Portfolio Table 81. Sanofi Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 85. Merck Vaccines Product Portfolio Table 86. Merck Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 90. Pfizer Vaccines Product Portfolio Table 91. Pfizer Recent Development Table 92. Novartis(GSK) Company Information Table 93. Novartis(GSK) Business Overview Table 94. Novartis(GSK) Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 95. Novartis(GSK) Vaccines Product Portfolio Table 96. Novartis(GSK) Recent Development Table 97. CSL Company Information Table 98. CSL Business Overview Table 99. CSL Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 100. CSL Vaccines Product Portfolio Table 101. CSL Recent Development Table 102. MedImmune LLC Company Information Table 103. MedImmune LLC Business Overview Table 104. MedImmune LLC Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 105. MedImmune LLC Vaccines Product Portfolio Table 106. MedImmune LLC Recent Development Table 107. J&J(Crucell) Company Information Table 108. J&J(Crucell) Business Overview Table 109. J&J(Crucell) Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 110. J&J(Crucell) Vaccines Product Portfolio Table 111. J&J(Crucell) Recent Development Table 112. China National Biotec Company Information Table 113. China National Biotec Business Overview Table 114. China National Biotec Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 115. China National Biotec Vaccines Product Portfolio Table 116. China National Biotec Recent Development Table 117. Tiantan Company Information Table 118. Tiantan Business Overview Table 119. Tiantan Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 120. Tiantan Vaccines Product Portfolio Table 121. Tiantan Recent Development Table 122. Hualan Company Information Table 123. Hualan Business Overview Table 124. Hualan Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 125. Hualan Vaccines Product Portfolio Table 126. Hualan Recent Development Table 127. Kangtai Company Information Table 128. Kangtai Business Overview Table 129. Kangtai Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 130. Kangtai Vaccines Product Portfolio Table 131. Kangtai Recent Development Table 132. Hissen Company Information Table 133. Hissen Business Overview Table 134. Hissen Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 135. Hissen Vaccines Product Portfolio Table 136. Hissen Recent Development Table 137. Jintan Company Information Table 138. Jintan Business Overview Table 139. Jintan Vaccines Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 140. Jintan Vaccines Product Portfolio Table 141. Jintan Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Vaccines Distributors List Table 145. Vaccines Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Vaccines Product Image Figure 2. Global Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vaccines Sales (2021-2032) & (K Pcs) Figure 5. Global Vaccines Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Recombinant Vaccines Image Figure 10. Viral Vaccines Image Figure 11. Polysaccharide Vaccines Image Figure 12. Others Image Figure 13. Global Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Vaccines Sales Volume Share by Type (2021-2032) Figure 16. Global Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Vaccines Sales Value Share by Type (2021-2032) Figure 19. Rabies vaccine Image Figure 20. Influenza vaccine Image Figure 21. HPV vaccine Image Figure 22. Hepatitis B Image Figure 23. Hepatitis A Image Figure 24. Leprosy vaccine Image Figure 25. Polio vaccine Image Figure 26. JE vaccine Image Figure 27. Others Image Figure 28. Global Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 29. Global Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 30. Global Vaccines Sales Volume Share by Application (2021-2032) Figure 31. Global Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 33. Global Vaccines Sales Value Share by Application (2021-2032) Figure 34. Global Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 35. Global Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 36. Global Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. Global Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 38. North America Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. North America Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Europe Vaccines Sales Value (2021-2032) & (US$ Million) Figure 41. Europe Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Asia-Pacific Vaccines Sales Value (2021-2032) & (US$ Million) Figure 43. Asia-Pacific Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 44. South America Vaccines Sales Value (2021-2032) & (US$ Million) Figure 45. South America Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 46. Middle East & Africa Vaccines Sales Value (2021-2032) & (US$ Million) Figure 47. Middle East & Africa Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 48. USA Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. USA Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. USA Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Canada Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Canada Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Canada Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Mexico Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Mexico Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Mexico Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Germany Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Germany Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Germany Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. France Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. France Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. France Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. U.K. Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. U.K. Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. U.K. Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Italy Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Italy Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Italy Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Spain Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Spain Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Spain Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Russia Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Russia Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Russia Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Netherlands Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Netherlands Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Netherlands Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Nordic Countries Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Nordic Countries Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Nordic Countries Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. China Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. China Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. China Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Japan Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Japan Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Japan Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. South Korea Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. South Korea Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. South Korea Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. India Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. India Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. India Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Australia Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Australia Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Australia Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Southeast Asia Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Southeast Asia Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Southeast Asia Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Brazil Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Brazil Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Brazil Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Argentina Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Argentina Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Argentina Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Chile Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Chile Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Chile Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Colombia Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Colombia Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Colombia Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Peru Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Peru Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Peru Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Saudi Arabia Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Saudi Arabia Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Saudi Arabia Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Israel Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Israel Arabia Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Israel Arabia Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. UAE Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. UAE Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. UAE Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Turkey Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Turkey Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Turkey Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Iran Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Iran Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Iran Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Egypt Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 130. Egypt Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 131. Egypt Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 132. Vaccines Value Chain Figure 133. Manufacturing Cost Structure Figure 134. Vaccines Sales Mode & Process Figure 135. Direct Comparison with Distribution Share Figure 136. Distributors Profiles Figure 137. Years Considered Figure 138. Research Process Figure 139. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Viral Vaccines
  • Polysaccharide Vaccines
  • Others
Applications
  • Rabies vaccine
  • Influenza vaccine
  • HPV vaccine
  • Hepatitis B
  • Hepatitis A
  • Leprosy vaccine
  • Polio vaccine
  • JE vaccine
  • Others
Companies covered
  • GSK
  • Sanofi
  • Merck
  • Pfizer
  • Novartis(GSK)
  • CSL
  • MedImmune LLC
  • J&J(Crucell)
  • China National Biotec
  • Tiantan
  • Hualan
  • Kangtai
  • Hissen
  • Jintan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vaccines Market Dynamics
  1. 2.1 Vaccines Industry Trends
  2. 2.2 Vaccines Industry Drivers
  3. 2.3 Vaccines Industry Opportunities and Challenges
  4. 2.4 Vaccines Industry Restraints
3 Vaccines Market by Company
  1. 3.1 Global Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Vaccines Company Product Type and Application
  8. 3.8 Global Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vaccines Market by Type
  1. 4.1 Vaccines Type Introduction
  2. 4.1.1 Recombinant Vaccines
  3. 4.1.2 Viral Vaccines
  4. 4.1.3 Polysaccharide Vaccines
  5. 4.1.4 Others
  6. 4.2 Global Vaccines Sales Volume by Type
  7. 4.2.1 Global Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vaccines Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Vaccines Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Vaccines Sales Value by Type
  11. 4.3.1 Global Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vaccines Sales Value by Type (2021-2032)
  13. 4.3.3 Global Vaccines Sales Value Share by Type (2021-2032)
5 Vaccines Market by Application
  1. 5.1 Vaccines Application Introduction
  2. 5.1.1 Rabies vaccine
  3. 5.1.2 Influenza vaccine
  4. 5.1.3 HPV vaccine
  5. 5.1.4 Hepatitis B
  6. 5.1.5 Hepatitis A
  7. 5.1.6 Leprosy vaccine
  8. 5.1.7 Polio vaccine
  9. 5.1.8 JE vaccine
  10. 5.1.9 Others
  11. 5.2 Global Vaccines Sales Volume by Application
  12. 5.2.1 Global Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  13. 5.2.2 Global Vaccines Sales Volume by Application (2021-2032)
  14. 5.2.3 Global Vaccines Sales Volume Share by Application (2021-2032)
  15. 5.3 Global Vaccines Sales Value by Application
  16. 5.3.1 Global Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  17. 5.3.2 Global Vaccines Sales Value by Application (2021-2032)
  18. 5.3.3 Global Vaccines Sales Value Share by Application (2021-2032)
6 Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vaccines Sales Value Share by Country, 2025 VS 2032
7 Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Vaccines Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Vaccines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Vaccines Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Vaccines Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Novartis(GSK)
  26. 8.5.1 Novartis(GSK) Company Information
  27. 8.5.2 Novartis(GSK) Business Overview
  28. 8.5.3 Novartis(GSK) Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis(GSK) Vaccines Product Portfolio
  30. 8.5.5 Novartis(GSK) Recent Developments
  31. 8.6 CSL
  32. 8.6.1 CSL Company Information
  33. 8.6.2 CSL Business Overview
  34. 8.6.3 CSL Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CSL Vaccines Product Portfolio
  36. 8.6.5 CSL Recent Developments
  37. 8.7 MedImmune LLC
  38. 8.7.1 MedImmune LLC Company Information
  39. 8.7.2 MedImmune LLC Business Overview
  40. 8.7.3 MedImmune LLC Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MedImmune LLC Vaccines Product Portfolio
  42. 8.7.5 MedImmune LLC Recent Developments
  43. 8.8 J&J(Crucell)
  44. 8.8.1 J&J(Crucell) Company Information
  45. 8.8.2 J&J(Crucell) Business Overview
  46. 8.8.3 J&J(Crucell) Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 J&J(Crucell) Vaccines Product Portfolio
  48. 8.8.5 J&J(Crucell) Recent Developments
  49. 8.9 China National Biotec
  50. 8.9.1 China National Biotec Company Information
  51. 8.9.2 China National Biotec Business Overview
  52. 8.9.3 China National Biotec Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 China National Biotec Vaccines Product Portfolio
  54. 8.9.5 China National Biotec Recent Developments
  55. 8.10 Tiantan
  56. 8.10.1 Tiantan Company Information
  57. 8.10.2 Tiantan Business Overview
  58. 8.10.3 Tiantan Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Tiantan Vaccines Product Portfolio
  60. 8.10.5 Tiantan Recent Developments
  61. 8.11 Hualan
  62. 8.11.1 Hualan Company Information
  63. 8.11.2 Hualan Business Overview
  64. 8.11.3 Hualan Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hualan Vaccines Product Portfolio
  66. 8.11.5 Hualan Recent Developments
  67. 8.12 Kangtai
  68. 8.12.1 Kangtai Company Information
  69. 8.12.2 Kangtai Business Overview
  70. 8.12.3 Kangtai Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kangtai Vaccines Product Portfolio
  72. 8.12.5 Kangtai Recent Developments
  73. 8.13 Hissen
  74. 8.13.1 Hissen Company Information
  75. 8.13.2 Hissen Business Overview
  76. 8.13.3 Hissen Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hissen Vaccines Product Portfolio
  78. 8.13.5 Hissen Recent Developments
  79. 8.14 Jintan
  80. 8.14.1 Jintan Company Information
  81. 8.14.2 Jintan Business Overview
  82. 8.14.3 Jintan Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Jintan Vaccines Product Portfolio
  84. 8.14.5 Jintan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccines Value Chain Analysis
  2. 9.1.1 Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccines Sales Mode & Process
  6. 9.2 Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccines Distributors
  9. 9.2.3 Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst